Biotech4 years ago
Algernon Pharmaceuticals to Commence Clinical Trials on Breakthrough DMT Stroke Treatment
Algernon Pharmaceuticals Inc. is a Canadian clinical-stage drug development company with a promising new treatment for post-stroke recovery based on sub-psychedelic doses of DMT. The company...